CN Patent

CN105503860B — 一类腈基取代的吡啶盐类jak抑制剂、制备方法及其用途

Assigned to Tianjin Xiaoxin Pharmaceutical Technology Co Ltd · Expires 2017-03-01 · 9y expired

What this patent protects

本发明涉及一类腈基取代的吡啶盐结构的JAK抑制剂、其制备方法、以及在制备治疗免疫性、炎性、自身免疫性或变应性疾病，或者移植排斥等疾病药物中的应用。

USPTO Abstract

本发明涉及一类腈基取代的吡啶盐结构的JAK抑制剂、其制备方法、以及在制备治疗免疫性、炎性、自身免疫性或变应性疾病，或者移植排斥等疾病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN105503860B
Jurisdiction: CN
Classification: —
Expires: 2017-03-01
Drug substance claim: No
Drug product claim: No
Assignee: Tianjin Xiaoxin Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.